XML 77 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingent Liabilities - Narrative (Details)
$ in Millions
26 Months Ended
Jan. 21, 2020
Jan. 09, 2020
USD ($)
Oct. 21, 2019
USD ($)
company
state_attorney
Dec. 31, 2019
USD ($)
state
complaint
state_attorney
relator
case
Jan. 06, 2020
company
Nov. 30, 2019
complaint
Oct. 31, 2019
complaint
Oct. 09, 2017
case
In re: National Prescription Opioid Litigation                
Loss Contingencies [Line Items]                
Complaints filed against the entity       2,700        
In re McKesson Corporation Stockholder Derivative Litigation                
Loss Contingencies [Line Items]                
Complaints filed against the entity               2
Number of new/additional suits filed       4        
Amount to be paid by insurance carriers under settlement agreement | $       $ 175        
Police & Fire Ret. Sys. of the City of Detroit v. McKesson Corporation, et al., Amalgamated Bank v. McKesson Corporation, et al., and Greene v. McKesson Corporation, et al.                
Loss Contingencies [Line Items]                
Number of new/additional suits filed       3        
Powell Prescription Center, et al. v. Surescripts, LLC, et al., and Intergrated Pharmaceutical Solutions LLC v. Surescripts, LLC                
Loss Contingencies [Line Items]                
Complaints filed against the entity | complaint             3  
Kennebunk Village Pharmacy, Inc. v. SureScripts, LLC, et al., 1:19-cv-7445; Whitman v. SureScripts, LLC et al., No. 1:19-cv-7448; BBK Global Corp. v. SureScripts, LLC et al., 1:19-cv-7640                
Loss Contingencies [Line Items]                
Complaints filed against the entity | complaint           3    
Consolidated Actions                
Loss Contingencies [Line Items]                
Complaints filed against the entity | complaint       6        
United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931                
Loss Contingencies [Line Items]                
Complaints filed against the entity | complaint       2        
Number of relators alleging violations | relator       2        
Subsequent Event | Related to Two Counties                
Loss Contingencies [Line Items]                
Payments under settlement agreement | $   $ 82            
Subsequent Event | United States District Court for the Northern District of California, Case No. 19-cv-02869                
Loss Contingencies [Line Items]                
Number of days given to file amended complaint 30 days              
Pending                
Loss Contingencies [Line Items]                
Complaints filed against the entity       360        
Number of states in which court cases are pending | state       44        
Number of attorney generals that have filed claims | state_attorney       20        
Pending | In re: National Prescription Opioid Litigation                
Loss Contingencies [Line Items]                
Number of cases selected for possible remand to other federal courts       3        
Number of state attorneys general involved in resolution discussions | state_attorney     4          
Award payable under proposed framework | $     $ 6,900          
Period over which award would be payable under proposed framework     18 years          
Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company     3          
Pending | Three Largest U.S. Pharmaceutical Distributors | In re: National Prescription Opioid Litigation                
Loss Contingencies [Line Items]                
Award payable under proposed framework | $     $ 18,000          
Period over which award would be payable under proposed framework     18 years          
Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company     3          
Pending | Subsequent Event | Three Largest U.S. Pharmaceutical Distributors | In re: National Prescription Opioid Litigation                
Loss Contingencies [Line Items]                
Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company         3